← Back to Search

Behavioral Intervention

BeatIt-MV Treatment Group for Depression

N/A

Recruiting

Led By Vanessa Bal, PhD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)

Awards & highlights

Study Summary

"This trial is testing a new therapy called BeatIt-2 to help people with intellectual disabilities and low mood who are minimally verbal due to autism."

Who is the study for?

This trial is for minimally verbal adults over 18 with Autism Spectrum Disorder and depression, who have a support person and can travel to Rutgers University in New Jersey or New York. It's not suitable for those without these specific conditions or support.Check my eligibility

What is being tested?

The study is testing BeatIt-MV, an adaptation of the BeatIt-2 intervention designed to help autistic individuals with intellectual disabilities and low mood by increasing their engagement in positive activities.See study design

What are the potential side effects?

Since this is a behavioral intervention, traditional medical side effects are not applicable. However, participants may experience changes in mood or behavior due to the nature of the therapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Anxiety Depression and Mood Scale (ADAMS)

Glasgow Depression Scale for Intellectual Disability (GDS)

Mood, Interest, & Pleasure Questionnaire (MIPQ)

Secondary outcome measures

Shalock Quality of Life Questionnaire

Vineland Adaptive Behavior Scale, 3rd edition (VABS-3)

Trial Design

1Treatment groups

Experimental Treatment

Group I: BeatIt-MV Treatment GroupExperimental Treatment1 Intervention

Participants, along with support persons, will complete 12 weekly sessions of the BeatIt-MV intervention. The support person will complete an initial session before commencement of the 12 weekly sessions.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor

429 Previous Clinical Trials

64,217 Total Patients Enrolled

11 Trials studying Depression

1,732 Patients Enrolled for Depression

Vanessa Bal, PhDPrincipal InvestigatorRutgers University - New Brunswick

1 Previous Clinical Trials

30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are potential candidates able to apply for participation in this ongoing trial?

"Certainly. According to the information provided on clinicaltrials.gov, this research endeavor is actively seeking volunteers. The trial was initially listed on November 1st, 2023 and last modified on March 20th, 2024. Recruitment aims to enroll a total of 15 participants at one designated site."

Answered by AI